SCHEMBL7493044

SCHEMBL7493044

CC(C)C(CC(=O)N(C)CCCc1ccc(Cl)cc1)C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TACR1 P25103 2/20 0.42
▸ HSD17B10 Q99714 1/20 0.41
▸ PPARA Q07869 4/20 0.41
▸ PPARG P37231 4/20 0.41
▸ FDPS P14324 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ ADAMTS4 O75173 1/20 0.39
▸ ADAMTS5 Q9UNA0 1/20 0.39
▸ AOC3 Q16853 1/20 0.38
▸ BCL2L1 Q07817 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ CTRC Q99895 1/20 0.38
▸ HDAC3 O15379 1/20 0.37
▸ HDAC4 P56524 1/20 0.37
▸ HDAC1 Q13547 1/20 0.37
▸ HDAC7 Q8WUI4 1/20 0.37
▸ HDAC2 Q92769 1/20 0.37
▸ HDAC10 Q969S8 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7493128 0.86 EPHX2 (0.40) TACR1PPARAPPARGFDPSALDH1A1
SCHEMBL7484970 0.79 MEN1 (0.47) PPARAPPARGFDPSALDH1A1RAB9A
SCHEMBL7493051 0.74 ALDH1A1 (0.58) HSD17B10ALDH1A1HTTHDAC3HDAC4
SCHEMBL7491428 0.72 HDAC3 (0.40) HSD17B10PPARAPPARGFDPSALDH1A1
SCHEMBL11551473 0.71 PPARG (0.51) HSD17B10PPARAPPARGTSHR
SCHEMBL11077889 0.69 CHRM1 (0.52) PPARGFDPSALDH1A1BCL2L1TSHR
SCHEMBL15650312 0.68 ALDH1A1 (0.70) ALDH1A1HTTRAB9AAOC3GAA
SCHEMBL7874806 0.68 PPARA (0.45) HSD17B10PPARAPPARGALDH1A1HTT
Hydrochloric Acid SCHEMBL9499441 0.67 FDPS (0.56) FDPSALDH1A1TSHRHDAC3HDAC4
SCHEMBL14528082 0.67 FDPS (0.62) FDPSAOC3BCL2L1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6462042-B1 TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME INHIBITORS; INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES, CANCER, CARDIO-VASCULAR DISEASES, RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, OSTEOPOROSIS, NEURODEGENERATION, ALZHEIMER'S DISEASE, STROKE DARWIN DISCOVERY LIMITED (GB) 2002-10-08 — — US disclosed
EP-1237867-A1 HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEINASE (MMP) INHIBITORS Darwin Discovery Limited (GB) 2002-09-11 — — EP disclosed
WO-2001044188-A1 HYDROXAMIC ACID DERIVATIVES AS MATRIX METALLOPROTEINASE (MMP) INHIBITORS DARWIN DISCOVERY LIMITED (GB) 2001-06-21 — — WO disclosed
Send feedback